Effect of the combination of systemic and locoregional therapy on tumor recurrence and survival after liver transplantation for hepatocellular carcinoma (HCC). This is an ASCO Meeting Abstract from ...
Patients who are not eligible for surgical resection may or may not be eligible for liver transplant, depending on the extent of their disease, as outlined by the Milan and other criteria above. Some ...
Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer Liver transplantation (LT) has been accepted as a cornerstone of care in hepatocellular carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results